GLP-1 · GLP-1 agonist · weekly · weight & glycemic control
Semaglutide
Semaglutide is a long-acting GLP-1 receptor agonist used for weight management and type-2 diabetes. Dose weekly, titrate slowly to minimize GI side effects.
Vial sizes
5 mg · 10 mg · 15 mg
Recommended BAC water
2 mL
Stable refrigerated
56 days
Titration schedule
| When | Dose | Units @ 2.5 mg/mL |
|---|---|---|
| Weeks 1–4 | 0.25 mg / week | 10.0 units |
| Weeks 5–8 | 0.5 mg / week | 20.0 units |
| Weeks 9–12 | 1.0 mg / week | 40.0 units |
| Weeks 13–16 | 1.7 mg / week | 68.0 units |
| Week 17+ | 2.4 mg / week (maintenance) | 96.0 units |
Reconstitution example
For a 5 mg vial + 2 mL BAC water
Concentration
2.50 mg/mL
Per 0.1 mL (10 units)
0.25 mg
Doses per vial (avg)
5.0
What to watch for
- Inject subcutaneously into abdomen, thigh, or upper arm. Rotate sites weekly.
- Most users tolerate slower titration better — stay on each dose 4+ weeks if side effects appear.
- Skip a dose? Take it within 5 days; if longer, skip and resume normal schedule.
Educational summary, not medical advice. Cross-reference current clinical literature and consult a licensed clinician before use.